Conference Summaries

Mediterranean diet

Mediterranean diet Mediterranean Diet to Reduce Risk and Prevent Micro- and Macrovascular Diabetes Complications of T2DM

Hypoglycemia, outcomes & QoL

Hypoglycemia, outcomes & QoL Impact of Hypoglycemia on Patient-Reported Outcomes and Quality-of-Life

T1D & pregnancy

Intensive Glycemic Treatment During Type 1 Diabetes Pregnancy

Diabetes & HIV

Management of Diabetes in HIV: Special Considerations

T1D, genes and environment – The TEDDY study

Lessons Learned from The Environmental Determinants of Diabetes in the Young (TEDDY) Study–Insights Into Early Autoimmune Type 1 Diabetes

Microbiome & body weight

Impact of the Gut Microbiome on Energy Regulation, Weight Management, and Eating Disorders

Therapy progression after basal insulin

Therapy Progression After Basal Insulin: GLP-1 Agonists vs. Prandial Insulin vs. Premixed Insulin

Precision medicine

Bench to Bedside: Precision Medicine for Diabetes – A Clinicians Perspective

Diabetic kidney disease & glycemic control

Pathophysiology of DKD and Glycemic Goals in Patients with Low GFR

Insulin therapy in youths with T1D

Insulin Therapy in Youth with Type 1 Diabetes Mellitus: Multiple Daily Injections or Insulin Pump Therapy

T1D & comorbidities

Beyond HbA1c—How Are We Managing Type 1 Diabetes Comorbidities?

The VADT-F study

The Veterans Affairs Diabetes Trial (VADT) at 15 Years

T1D & social context

Understanding the Social Context of Managing Diabetes: What’s Life Really Like?

Diabetes & cognitive impairment

Diabetes Mellitus: Cognitive Effects and Treatment Opportunities

Beta cell decline – The RISE study

The Restoring Insulin Secretion (RISE) Study in Youth and Adults–Baseline Data and Results of the Pediatric Medication Study

Rapid acting insulins—To the future and back

Fast and Furious or Just Marketing Fiction? Expectations From New and Developing Rapid-Acting Insulins

Draft ADA/EASD Consensus Report 2018

Management of Hyperglycemia in Type 2 Diabetes–Draft ADA/EASD Consensus Report 2018

SGLT inhibition for T1D

SGLT Inhibition for Type 1 Diabetes Management–How Far Have We Gone?

Download the ADA 2018 Slide Kit